The DEEP project has received research funding from the European Union under the 7th Framework Programme

News | DEEP Project

DEEP-2 Study results published on EU and US CTs registries

Maggio 10, 2021
|
Comments off
|

The results of the DEEP-2 paediatric clinical trial are now available on ClinicalTrials.org as well as on the EU Clinical Trials Register.

DEEP-2 is a multi-centre, randomised, open-label, non-inferiority active […]

Share
Read more →

DEEP-2 study: the final results are available on EudraCT

Gennaio 7, 2020
|
Comments off
|

We are glad to announce that the DEEP-2 study Phase III multicentre, randomised, open label, non-inferiority active-controlled trial aimed at comparing for the first time the efficacy of deferiprone (DFP) versus deferasirox (DFX) in paediatric patients aged from 1 month to less than 18 years […]

Share
Read more →

DEEP project – “Success story” for European Commission’s DG Research and Innovation

Settembre 7, 2018
|
Comments off
|

The European Commission’s DG Research and Innovation published on the European Commission (EC) official website an article regarding the successful outcomes of the DEEP project (DEferiprone Evaluation in Paediatrics), as an example of particularly fruitful project. DEEP is a 6-year European project coordinated by Consorzio per […]

Share
Read more →

DEEP Final meeting: preliminary results

Marzo 12, 2018
|
Comments off
|

The DEEP (DEferiprone Evaluations in paediatrics) project, a 6-year European Project (FP7) coordinated by CVBF and comprising 23 recruiting centres in European and non-European countries, scientific partners from several European countries and a pharmaceutical group based in Canada, is at the final rush and has presented […]

Share
Read more →
1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next page ›